Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Semler ScientificViewRayCuteraStereotaxisZynex
SymbolOTCMKTS:SMLRNASDAQ:VRAYNASDAQ:CUTRNYSEAMERICAN:STXSNASDAQ:ZYXI
Price Information
Current Price$109.90$4.21$29.31$8.13$15.61
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.21.31.30.61.8
Analysis Score1.51.31.41.53.3
Community Score2.52.82.60.03.1
Dividend Score0.00.00.00.00.0
Ownership Score0.01.71.70.80.8
Earnings & Valuation Score1.90.60.60.61.9
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$110.50$4.50$30.67$7.33$21.63
% Upside from Price Target0.55% upside6.89% upside4.63% upside-9.80% downside38.53% upside
Trade Information
Market Cap$738.20 million$704.31 million$536.51 million$611.16 million$535.37 million
Beta1.110.641.61.560.6
Average Volume19,2002,007,381229,679375,964607,333
Sales & Book Value
Annual Revenue$32.77 million$87.78 million$181.71 million$28.90 million$45.47 million
Price / Sales22.537.712.8720.8411.97
Cashflow$3.15 per shareN/AN/AN/A$0.35 per share
Price / Cash34.91N/AN/AN/A44.38
Book Value$2.00 per share$1.47 per share$3.23 per share$0.34 per share$0.60 per share
Price / Book54.952.869.0723.9126.02
Profitability
Net Income$15.08 million$-120,200,000.00$-12,350,000.00$-4,590,000.00$9.49 million
EPS$1.88($1.18)($0.88)($0.10)$0.28
Trailing P/E Ratio77.39N/AN/AN/A47.30
Forward P/E Ratio48.41N/AN/AN/A30.02
P/E Growth1.48N/AN/AN/AN/A
Net Margins32.08%-166.74%-18.83%-24.54%18.08%
Return on Equity (ROE)67.38%-63.41%-61.21%-22.78%50.67%
Return on Assets (ROA)52.42%-36.34%-25.31%-13.15%35.56%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.26%0.14%0.05%0.01%
Current Ratio3.85%3.90%2.13%4.01%4.96%
Quick Ratio3.85%3.19%1.48%3.79%4.17%
Ownership Information
Institutional Ownership Percentage12.13%83.03%87.79%54.34%29.57%
Insider Ownership Percentage13.60%15.48%2.30%34.91%50.54%
Miscellaneous
Employees86236447120768
Shares Outstanding6.72 million160.80 million17.78 million74.08 million34.86 million
Next Earnings Date5/3/2021 (Estimated)4/29/2021 (Estimated)5/6/2021 (Estimated)5/4/2021 (Estimated)N/A
OptionableNot OptionableOptionableOptionableOptionableOptionable
SourceHeadline
Zynex Schedules 2021 First Quarter Earnings Call - Yahoo FinanceZynex Schedules 2021 First Quarter Earnings Call - Yahoo Finance
finance.yahoo.com - April 19 at 10:19 AM
Zynex Schedules 2021 First Quarter Earnings CallZynex Schedules 2021 First Quarter Earnings Call
finance.yahoo.com - April 19 at 10:19 AM
Muscle Stimulation Devices Market Worth Observing Growth | Zynex, Omron, Axiobionics – Los Hijos de la Malinche - Los Hijos de la MalincheMuscle Stimulation Devices Market Worth Observing Growth | Zynex, Omron, Axiobionics – Los Hijos de la Malinche - Los Hijos de la Malinche
loshijosdelamalinche.com - April 17 at 8:07 AM
$ZYXI Pre-earnings Momentum Trade With a Technical Trigger - CML News$ZYXI Pre-earnings Momentum Trade With a Technical Trigger - CML News
cmlviz.com - April 17 at 12:13 AM
Electronic Muscle Stimulator Market Is Expected to Grow at a Healthy CAGR With Top Players: Compex, Omron, RS Medical, NeuroMetrix, Zynex Inc., etc – Los Hijos de la Malinche - Los Hijos de la MalincheElectronic Muscle Stimulator Market Is Expected to Grow at a Healthy CAGR With Top Players: Compex, Omron, RS Medical, NeuroMetrix, Zynex Inc., etc – Los Hijos de la Malinche - Los Hijos de la Malinche
loshijosdelamalinche.com - April 16 at 7:12 PM
Zynex Inc.: Demand-Pull, Order Growth To Finish 2020, Inventory Still Questionable - Seeking AlphaZynex Inc.: Demand-Pull, Order Growth To Finish 2020, Inventory Still Questionable - Seeking Alpha
seekingalpha.com - April 16 at 9:11 AM
Neuro-Stimulators Market 2021 Competitive Dynamics & Outlook 2027 | Nevro, DJO, Cyberonics, Medtronic, Uroplasty, Zynex, ST.Jude, NeuroMetrix, Boston Scientific - Los Hijos de la MalincheNeuro-Stimulators Market 2021 Competitive Dynamics & Outlook 2027 | Nevro, DJO, Cyberonics, Medtronic, Uroplasty, Zynex, ST.Jude, NeuroMetrix, Boston Scientific - Los Hijos de la Malinche
loshijosdelamalinche.com - April 16 at 8:36 AM
Futuristics Overview of Muscle Stimulator Market: Industry Insights and Forecast 2021-2026 by Omron, Zynex, NeuroMetrix, DJO Global, RS Medical,, and more | Affluence - Los Hijos de la MalincheFuturistics Overview of Muscle Stimulator Market: Industry Insights and Forecast 2021-2026 by Omron, Zynex, NeuroMetrix, DJO Global, RS Medical,, and more | Affluence - Los Hijos de la Malinche
loshijosdelamalinche.com - April 16 at 8:36 AM
Apr 14, 2021 - Mesirow Financial Investment Management, Inc. Buys Duluth Holdings Inc, OneWater Marine Inc, Civista Bancshares Inc, Sells Mohawk Group Holdings Inc, CareCloud Inc, Cohu Inc - GuruFocus.comApr 14, 2021 - Mesirow Financial Investment Management, Inc. Buys Duluth Holdings Inc, OneWater Marine Inc, Civista Bancshares Inc, Sells Mohawk Group Holdings Inc, CareCloud Inc, Cohu Inc - GuruFocus.com
gurufocus.com - April 14 at 3:22 PM
Portable Electrical Muscle Stimulator Market Estimated To Flourish By 2027 Competitors Like- DJO Global, Inc., Zynex, Inc., NeuroMetrix, Inc.,OMRON Corporation, Zimmer MedizinSysteme GmbH, BioMedical Life Systems, EMS Physio Ltd – FLA News - FLA NewsPortable Electrical Muscle Stimulator Market Estimated To Flourish By 2027 Competitors Like- DJO Global, Inc., Zynex, Inc., NeuroMetrix, Inc.,OMRON Corporation, Zimmer MedizinSysteme GmbH, BioMedical Life Systems, EMS Physio Ltd – FLA News - FLA News
flanewsonline.com - April 14 at 12:26 PM
Neurostimulation Device Market Current Status and 2026 Future Projections- Zynex, Cyberonics, Boston Scientific, DJO, Nevro, NeuroMetrix, ST.Jude – Jumbo News - Jumbo NewsNeurostimulation Device Market Current Status and 2026 Future Projections- Zynex, Cyberonics, Boston Scientific, DJO, Nevro, NeuroMetrix, ST.Jude – Jumbo News - Jumbo News
jumbonews.co.uk - April 13 at 11:23 AM
Zynex Announces 140% Year over Year Order Growth in Q1-2021 - BioSpaceZynex Announces 140% Year over Year Order Growth in Q1-2021 - BioSpace
biospace.com - April 12 at 5:42 PM
Zynex, Inc. (ZYXI) Announces 140% Year over Year Order Growth in Q1 - StreetInsider.comZynex, Inc. (ZYXI) Announces 140% Year over Year Order Growth in Q1 - StreetInsider.com
streetinsider.com - April 12 at 5:37 PM
Zynex 1Q21 orders grow 140% Y/Y, sees revenues estimates in-line - Seeking AlphaZynex 1Q21 orders grow 140% Y/Y, sees revenues estimates in-line - Seeking Alpha
seekingalpha.com - April 12 at 5:37 PM
Impact of COVID 19 on Electrical Stimulation Devices Market Checkout the Unexpected Future Growth, and Forecast to 2027 – ROUGH Magazine - ROUGH MagazineImpact of COVID 19 on Electrical Stimulation Devices Market Checkout the Unexpected Future Growth, and Forecast to 2027 – ROUGH Magazine - ROUGH Magazine
rough.asia - April 12 at 1:46 PM
Impact of COVID 19 on Electrotherapy System Market Projected To Augment At A Notable Cagr During The Forecast Period Until 2027 – ROUGH Magazine - ROUGH MagazineImpact of COVID 19 on Electrotherapy System Market Projected To Augment At A Notable Cagr During The Forecast Period Until 2027 – ROUGH Magazine - ROUGH Magazine
rough.asia - April 12 at 1:46 PM
Zynex Announces 140% Year over Year Order Growth in Q1-2021 - PRNewswireZynex Announces 140% Year over Year Order Growth in Q1-2021 - PRNewswire
prnewswire.com - April 12 at 12:36 PM
Zynex Announces 140% Year over Year Order Growth in Q1-2021Zynex Announces 140% Year over Year Order Growth in Q1-2021
finance.yahoo.com - April 12 at 12:36 PM
Continued growth pushes Zynex into new HQ siteContinued growth pushes Zynex into new HQ site
medicalplasticsnews.com - April 12 at 7:36 AM
Zacks: Brokerages Expect Zynex, Inc. (NASDAQ:ZYXI) Will Announce Quarterly Sales of $23.63 MillionZacks: Brokerages Expect Zynex, Inc. (NASDAQ:ZYXI) Will Announce Quarterly Sales of $23.63 Million
americanbankingnews.com - April 10 at 4:56 AM
Form 8-K ZYNEX INC For: Apr 08 - StreetInsider.comForm 8-K ZYNEX INC For: Apr 08 - StreetInsider.com
streetinsider.com - April 9 at 10:57 AM
Zynex Growth Leads to New Corporate Headquarters - PRNewswireZynex Growth Leads to New Corporate Headquarters - PRNewswire
prnewswire.com - April 9 at 10:57 AM
Zynex Growth Leads to New Corporate HeadquartersZynex Growth Leads to New Corporate Headquarters
finance.yahoo.com - April 9 at 10:57 AM
Could The Market Be Wrong About Zynex, Inc. (NASDAQ:ZYXI) Given Its Attractive Financial Prospects? - Yahoo FinanceCould The Market Be Wrong About Zynex, Inc. (NASDAQ:ZYXI) Given Its Attractive Financial Prospects? - Yahoo Finance
finance.yahoo.com - April 8 at 5:36 PM
Could The Market Be Wrong About Zynex, Inc. (NASDAQ:ZYXI) Given Its Attractive Financial Prospects?Could The Market Be Wrong About Zynex, Inc. (NASDAQ:ZYXI) Given Its Attractive Financial Prospects?
finance.yahoo.com - April 8 at 5:36 PM
DateCompanyBrokerageAction
2/25/2021Semler ScientificB. RileyBoost Price Target
11/6/2020Semler ScientificLake Street CapitalBoost Price Target
10/5/2018Semler ScientificDougherty & CoInitiated Coverage
4/1/2021ViewRayBTIG ResearchUpgrade
1/12/2021ViewRayPiper SandlerBoost Price Target
1/6/2021ViewRayMorgan StanleyBoost Price Target
6/23/2020ViewRayOppenheimerReiterated Rating
6/15/2020ViewRayCantor FitzgeraldInitiated Coverage
4/28/2020ViewRayGuggenheimDowngrade
3/13/2020ViewRayMizuhoReiterated Rating
10/15/2019ViewRayPiper Jaffray CompaniesSet Price Target
9/14/2020CuteraStephensBoost Price Target
5/8/2020CuteraMaxim GroupReiterated Rating
5/5/2020CuteraStifel NicolausUpgrade
8/22/2019CuteraSidotiDowngrade
12/30/2020StereotaxisNorthland SecuritiesReiterated Rating
4/19/2020StereotaxisCowenInitiated Coverage
9/14/2020ZynexHC WainwrightUpgrade
(Data available from 4/19/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.